Digital drug delivery systems collate big data to identify insights that enhance patient outcomes, expediting regulatory approval and encouraging real-world adoption. RYAH Group specialises in dosage control for plant-based interventions, strengthening the safety and efficacy of psychedelic medicines.
Read More
It is estimated 10 million US citizens have a gambling addiction, spending US$500 billion every year.
Read More
The measure failed to garner sufficient support in the Assembly, with greater research required.
Read More
Red Light Holland and Creso Pharma terminate merger.
FSD Pharma to acquire Lucid Psycheceuticals for US$9m.
Psychedelic treatments are here, but doctors aren’t prepared.
Braxia Scientific reports Q1 2022 financial results.
PsyBio Therapeutics announces Q2 2022 financial results.
Biomind Labs to advance Phase II clinical trials on DMT.
Braxia Scientific to conduct multi-dose psilocybin clinical trials.
Mindset Pharma releases results from preclinical trials.
MYND Life Sciences to release debenture units worth up to C$3m.
Filament completes export of psilocybin to the United States.
MINDCURE releases digital therapeutics platform.
A ‘trip’ to the boardroom: A look at psychedelic medicine’s top players.
Ketamine One subsidiary expands with veteran-focused clinics.
Ketamine One partners with OVR Technology for scent-enabled virtual reality.
Silo files patents for central nervous system delivery.
The weight-loss tool that could help nearly 1.9 billion people.
Ei.Ventures partners with Tioga Research to develop psilocin patch.
Durham start-up founded by Duke University scientists thinks it has a way to improve antidepressants.
PharmaDrug signs clinical research agreement with Johns Hopkins University.
Psilera collaborates with the National Institute on Drug Abuse to study DMT.
Will a psilocybin patch be the next big thing in psychedelics?
Suddenly, we have more antidepressant alternatives than conventional depression-treating drugs.
A trip into the therapeutic potential of Australia’s native magic mushrooms.
The role of compounding pharmacies in the ketamine therapy field.
Do psilocybin mushrooms actually offer a glimpse of hidden reality?
Researchers are closer to explaining how ketamine treats depression.
Denver activists push to expand psilocybin decriminalisation to include gifting.